Compare ARK Genomic Revolution ETF (ARKG) vs DigitalOcean Holdings Inc (DOCN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs DigitalOcean Holdings Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while DigitalOcean Holdings Inc trades at $128.89 (market cap $13.62B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, DigitalOcean Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | DOCN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $181.29 |
52-Week Low | $23.09 | $25.74 |
Market Cap | — | $13.62B |
Enterprise Value | — | $14.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
DigitalOcean (DOCN) trades at $130.49, down 7.38% over the past 24 hours, amid a bearish technical signal. The company reported strong Q1 2026 earnings of $0.44 per share, beating expectations, and anticipates record Q2 2026 results with remaining performance obligations exceeding $800 million. Revenue grew to $901.43 million in 2025, with a net income margin of 24.97%, though valuation ratios remain elevated with a P/E of 57.23. Analyst consensus is bullish with a $174.80 price target.
Outlook remains positive due to accelerating AI-driven cloud demand and strong execution, but risks include high valuation multiples, negative shareholder equity, and competitive pressure from hyperscalers. The stock offers growth potential if AI adoption continues, yet investors should monitor debt levels and margin sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →
